MWNA
CVRX icon

Marshall Wace North America’s CVRx CVRX Stock Holding History

Marshall Wace North America’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,000
Closed -$701K – 1479
2021
Q2 		$701K Buy
+25,000
New +$700K ﹤0.01% 1099

Other funds holding CVRX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Marshall Wace North America's CVRX Position: Q3 2021 in Review

Marshall Wace North America sold out of CVRx (CVRX) in Q3 2021, closing a stake of 25,000 shares — an estimated $701K sold.

Marshall Wace North America first reported a position in CVRX in Q2 2021 and held it in 1 quarter. The position peaked at $701K in Q2 2021. 50 funds tracked by Wall St. Rank hold CVRX as of Q3 2021.

  • Marshall Wace North America reported no remaining CVRx position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 25,000 CVRx shares in Q3 2021, an estimated $701K.
  • Marshall Wace North America first reported a position in CVRx in Q2 2021 and held it in 1 quarter.
  • Marshall Wace North America's CVRx position peaked at $701K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held CVRx as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.